NCT06060600View on ClinicalTrials.gov

A Retrospective Analysis of Suramin Treatment for Stage 1 TBR

CompletedOBSERVATIONAL

Enrollment

345

Participants

Timeline

Start Date

January 2, 2023

Primary Completion Date

August 2, 2023

Study Completion Date

August 2, 2023

Conditions

Trypanosoma Brucei Rhodesiense; Infection

Trial Locations (1)

10591

PaxMedica, Tarrytown

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Paxmedica

INDUSTRY